Christopher E. Nelson Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Assistant Professor

University of Arkansas at Little Rock

faculty

37 h-index 141 pubs 5,693 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Christopher E. Nelson's research focuses on the application of genome editing technologies, particularly CRISPR-Cas9, for therapeutic purposes, with a significant emphasis on Duchenne muscular dystrophy (DMD). His work investigates the challenges and optimizations related to the delivery of CRISPR-Cas9 systems, including exploring Cas9-specific immune responses that can impact therapy efficacy in preclinical models. Nelson has also examined the precision and efficacy of RNA-guided DNA integration in muscle loci and contributed to the preclinical development of genome editing strategies for DMD, such as exon skipping.

Beyond gene editing for genetic disorders, Nelson's research interests extend to other areas of biomedical investigation. This includes studies on perfusion and angiogenesis markers in colorectal tumors, exploring different dosing strategies for cancer treatment. His work also encompasses the characterization of biopolymers, such as guar gum, examining their chemical composition and physical properties. Nelson leads a research group and has a publication record that includes work with collaborators from the University of Arkansas at Little Rock and the University of Arkansas at Fayetteville.

Metrics

  • h-index: 37
  • Publications: 141
  • Citations: 5,693

Selected Publications

  • Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy (2025) DOI
  • Standardizing a Protocol for Streamlined Synthesis and Characterization of Lipid Nanoparticles to Enable Preclinical Research and Education (2025) DOI
  • Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping (2025) DOI
  • Resistance to Acetyl Coenzyme A Carboxylase (ACCase) Inhibitor in Lolium multiflorum: Effect of Multiple Target-Site Mutations (2024) DOI
  • Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci (2024) DOI
  • Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing (2024) DOI
  • Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci (2024) DOI
  • PINE-TREE enables efficient enrichment of prime-edited hPSCs (2023) DOI
  • Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023) DOI
  • Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies (2022) DOI
  • Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies (2022) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics